Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller
Cell Host & Microbe · 2023-08 · 31 (8) · 1275-1287.e8
DOI: 10.1016/j.chom.2023.06.006 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Host & Microbe, 2023-08. Verfasst von Luis M Molinos-Albert und 16 weiteren Autor:innen. Beteiligte Einrichtung: Humoral Immunology Unit, Institut Pasteur, Université Paris Cité, INSERM U1222, Paris 75015, France. Hauptthemen laut MEDLINE: HIV-1, HIV Infections. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: Institut Pasteur, Cornell University, Agence Nationale de Recherches sur le Sida et les Hépatites Virales.
Abstract (Originalsprache)
HIV-1 broadly neutralizing antibodies (bNAbs) can decrease viremia but are usually unable to counteract autologous viruses escaping the antibody pressure. Nonetheless, bNAbs may contribute to natural HIV-1 control in individuals off antiretroviral therapy (ART). Here, we describe a bNAb B cell lineage elicited in a post-treatment controller (PTC) that exhibits broad seroneutralization and show that a representative antibody from this lineage, EPTC112, targets a quaternary epitope in the glycan-V3 loop supersite of the HIV-1 envelope glycoprotein. The cryo-EM structure of EPTC112 complexed with soluble BG505 SOSIP.664 envelope trimers revealed interactions with N301- and N156-branched N-glycans and the 324GDIR327 V3 loop motif. Although the sole contemporaneous virus circulating in this PTC was resistant to EPTC112, it was potently neutralized by autologous plasma IgG antibodies. Our findings illuminate how cross-neutralizing antibodies can alter the HIV-1 infection course in PTCs and may control viremia off-ART, supporting their role in functional HIV-1 cure strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Humoral Immunology Unit, Institut Pasteur, Université Paris Cité, INSERM U1222, Paris 75015, France.
- NanoImaging Core Facility, Centre de Ressources et Recherches Technologiques (C2RT), Université Paris Cité, Institut Pasteur, Paris 75015, France.
- Université de Tours, INSERM U1259, Tours 37032, France.
- Université Cité, Faculté de Médecine, Paris 75014, France; INSERM U1016, CNRS UMR8104, Institut Cochin, Paris 75014, France; AP-HP, Service de Virologie, Hôpital Cochin, Paris 75014, France.
- Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Université de Paris, Paris 75006, France.
- Viral Reservoirs and Immune control Unit, Institut Pasteur, Université Paris Cité, Paris 75015, France; HIV, Inflammation and Persistence Unit, Institut Pasteur, Université Paris Cité, Paris 75015, France.
Förderung
- Institut Pasteur
- Cornell University
- Agence Nationale de Recherches sur le Sida et les Hépatites Virales
- Institut National de la Santé et de la Recherche Médicale
- National Institutes of Health
Zitieren
APA
Molinos-Albert, L. M., Baquero, E., Bouvin-Pley, M., Lorin, V., Charre, C., Planchais, C., Dimitrov, J. D., Monceaux, V., Vos, M., ANRS VISCONTI Study Group, Hocqueloux, L., Berger, J. L., Seaman, M. S., Braibant, M., Avettand-Fenoël, V., Sáez-Cirión, A., & Mouquet, H. (2023). Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller. Cell Host & Microbe, 31(8), 1275-1287.e8. https://doi.org/10.1016/j.chom.2023.06.006
Vancouver
Molinos-Albert LM, Baquero E, Bouvin-Pley M, Lorin V, Charre C, Planchais C, et al. Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller. Cell Host & Microbe. 2023;31(8):1275-1287.e8. doi:10.1016/j.chom.2023.06.006
BibTeX
@article{MolinosAlbert2023,
author = {Molinos-Albert, Luis M and Baquero, Eduard and Bouvin-Pley, Mélanie and Lorin, Valérie and Charre, Caroline and Planchais, Cyril and Dimitrov, Jordan D and Monceaux, Valérie and Vos, Matthijn and ANRS VISCONTI Study Group, ANRS VISCONTI Study Group and Hocqueloux, Laurent and Berger, Jean-Luc and Seaman, Michael S and Braibant, Martine and Avettand-Fenoël, Véronique and Sáez-Cirión, Asier and Mouquet, Hugo},
title = {Anti-V1/V3-glycan broadly HIV-1 neutralizing antibodies in a post-treatment controller},
journal = {Cell Host & Microbe},
year = {2023},
volume = {31},
number = {8},
pages = {1275--1287.e8},
doi = {10.1016/j.chom.2023.06.006}
}
EUVIMED